About PR Pharma Engineers Private Limited
Data last updated:
PR Pharma Engineers Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 03 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U29100TG2019PTC133117. Its GSTIN is 36AAKCP5882C1Z6 (Telangana).
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹8 Cr. It is led by directors Pulla Reddy Koppula (Managing Director) and Sailaja Rani Koppula.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.113/A/1 Ida Phase – II Cherlapally, Hyderabad, Telangana, India – 500051.
As per the financials filed for FY 2025, the company reported a revenue of ₹62.91 Cr, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹1.51 Cr (net margin 2.4%) and EBITDA of ₹3.42 Cr (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 13% over five years.
The company has about 262 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Pharma Engineers. As per MCA filings, the company has open charges of ₹20.53 Cr on record. The company has 1 deal on record (1 funding round), with disclosed funding of ₹7.9 Cr; the latest was in March 2020. Its 10 peer companies in the Healthcare industry (Medical and Laboratory Equipment) are compared by revenue, 5 larger and 5 smaller; the largest is Verder Scientific Private Limited with revenue of ₹64.44 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmaengineers.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No.113/A/1 Ida Phase – II Cherlapally, Hyderabad, Telangana, India – 500051
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of PR Pharma Engineers Private Limited
The main business activity of PR Pharma Engineers is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of PR Pharma Engineers Private Limited FY 2025 filings available
PR Pharma Engineers Private Limited reported revenue of ₹62.91 Cr (down 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of PR Pharma Engineers Private Limited
Revenue fell 14% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 13%. EBITDA fell 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of PR Pharma Engineers Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.42 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.51 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of PR Pharma Engineers Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of PR Pharma Engineers are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of PR Pharma Engineers Private Limited
PR Pharma Engineers Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Verder Scientific Private Limited | ₹64.44 Cr (FY 2024) | •••• | •••• | 61.0% | •••• | Hyderabad, Telangana, India |
| Eie Instruments Private Limited | ₹63.95 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Ahmedabad, Gujarat, India |
| Toshniwal Instruments (Madras) Private Limited | ₹63.87 Cr (FY 2024) | •••• | •••• | 12.0% | •••• | Chennai, Tamil Nadu, India |
| Armax Health Private Limited | ₹63.39 Cr (FY 2020) | •••• | •••• | 129.0% | •••• | Mumbai, Maharashtra, India |
| Metal Power Analytical Private Limited | ₹63.14 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Mumbai, Maharashtra, India |
| PR Pharma Engineers Private Limited this company | ₹62.91 Cr (FY 2025) | •••• | •••• | -14.0% | •••• | Hyderabad, Telangana, India |
| Sigma Surgical Private Limited | ₹60.36 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Ahmedabad, Gujarat, India |
| Jeol India Private Limited | ₹60.05 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | New Delhi, Delhi, India |
| Labtech Health Care India Private Limited | ₹59.52 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Japur, Rajasthan, India |
| Shree Balaji Surgical Private Limited | ₹59.32 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Mumbai, Maharashtra, India |
| Adonis Medical Systems Private Limited | ₹59.01 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below PR Pharma Engineers by revenue in the Healthcare industry (Medical and Laboratory Equipment), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of PR Pharma Engineers Private Limited
PR Pharma Engineers Private Limited is audited by S.KASTHURI RENGAN & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S.KASTHURI RENGAN & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of PR Pharma Engineers Private Limited
PR Pharma Engineers has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pulla Reddy Koppula Also directs: Radiant PR Airtech Private Limited | Managing Director | 03 Jun 2019 | 7 Years 4 Months | Current |
| Sailaja Rani Koppula Also directs: Radiant PR Airtech Private Limited | Director | 03 Jun 2019 | 7 Years 4 Months | Current |
Ownership and Shareholding of PR Pharma Engineers Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of PR Pharma Engineers Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jan 2020 | State Bank of India | ₹20.53 Cr | Open |
Total charge records: 1 View all charges
Deals & Funding of PR Pharma Engineers Private Limited
PR Pharma Engineers Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹7.9 Cr; the latest was in March 2020.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Funding round | ₹7.9 Cr | Investors: 2 individuals |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Associated Brands with PR Pharma Engineers Private Limited
PR Pharma Engineers operates one associated brand: Pharma Engineers. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of air handling units and HVAC equipments to pharma companies | pharmaengineers.com |
Employees and EPFO Compliance at PR Pharma Engineers Private Limited
PR Pharma Engineers Private Limited has a workforce of 262 employees as of Mar 21, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on PR Pharma Engineers Private Limited
PR Pharma Engineers Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Pulla Reddy Koppula ceased to be Director on 15 Feb 2021.
Credit Ratings, Litigation & Regulatory Alerts for PR Pharma Engineers Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by PR Pharma Engineers Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of PR Pharma Engineers Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of PR Pharma Engineers Private Limited
PR Pharma Engineers has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAKCP5882C1Z6 | Telangana | Active | 11 Jun 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of PR Pharma Engineers Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PR Pharma Engineers Private Limited
PR Pharma Engineers is an active private limited company based in Hyderabad, Telangana, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 03 June 2019 (7+ years old) and is registered under CIN U29100TG2019PTC133117.
PR Pharma Engineers reported revenue of ₹62.91 Cr for FY 2025 (down 14% YoY).
PR Pharma Engineers has 2 current directors:
- Pulla Reddy Koppula - Managing Director
- Sailaja Rani Koppula - Director
PR Pharma Engineers reported a net profit of ₹1.51 Cr (net margin 2.4%) and EBITDA of ₹3.42 Cr (EBITDA margin 5.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of PR Pharma Engineers is 3% over three years and 13% over five years. In the latest year (FY 2025) revenue fell 14%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of PR Pharma Engineers is 36AAKCP5882C1Z6, registered in Telangana.
The CIN (Corporate Identification Number) of PR Pharma Engineers is U29100TG2019PTC133117. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
PR Pharma Engineers was incorporated on 03 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
PR Pharma Engineers has 1 deal on record (1 funding round), with disclosed funding of ₹7.9 Cr; the latest was in March 2020.
The peers of PR Pharma Engineers by revenue are Verder Scientific Private Limited, Eie Instruments Private Limited, Toshniwal Instruments (Madras) Private Limited, Armax Health Private Limited, Metal Power Analytical Private Limited and 5 more, all in the Healthcare industry (Medical and Laboratory Equipment).
Pulla Reddy Koppula ceased to be Director on 15 Feb 2021. Pulla Reddy Koppula was appointed as Managing Director on 03 Jun 2019. Sailaja Rani Koppula was appointed as Director on 03 Jun 2019.